Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam

Thrombosis Research

Volumn 99, Issue 6, 2000, Pages 595-602

  Aguejouf, Omar ^a   Malfatti, Emmanuelle ^a   Belon, Philippe ^a   Doutremepuich, Christian ^a  

^a Faculté de Pharmacie   (France)

Author keywords

Aspirin; Hemorrhage; Neutralization; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOGENESIS; THROMBOSIS; THROMBUS;

EID: 0034666738     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00270-X     Document Type: Article

References (28)

1. Pedersen A.K., Fitzgerald G.A. The human pharmacology of platelet inhibition. pharmacokinetics relevant to drug action Circulation. 72:1985;1164-1176.
2. Bochner F., Somogyi A.A., Wilson K.M. Bioinequivalence of four 100 mg oral aspirin formulations in healthy volunteers. Clin Pharmacol Kinet. 21:1991;394-399.
3. Allain H., Belier A., Lablach Combier B. Prévention secondaire des pathologies athrothrombotiques. à equelle dose prescrire l'aspirine? La Lettre du Pharmacologue. 7:1993;3-7.
4. Harker L., Fuster U. Pharmacology of platelet inhibitors. J Am Coll Cardiol. 8:1986;21B-32B.
5. Weskler B.B., Tack-Goldman K., Subramanian V.A., Gay W.A. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. Circulation. 71:1985;332-340.
6. Pedersen A.K., Fitzgerald G.A. Dose-related kinetics of aspirin. presystemic acetylation of platelet cyclooxygenase N Engl J Med. 311:1984;1206-1211.
7. Moncada S., Vane J.R. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull. 34:1979;129.
8. 2) synthesis in humans and rabbits. J Cardiovasc Pharmacol. 2:1980;387-397.
9. Hanley S.P., Beran J., Cockbill S.R., Heptinstall S. Differential inhibition by low dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet. I:1981;969-971.
10. Preston F.E., Greaves M., Jackson C.A. Cumulative inhibitory effect of daily 40 mg aspirin on prostacyclin synthesis. Lancet. I:1981;1211-1212.
11. Vinikka L., Ylikorkala O. Effect of various doses of acetylsalicylic acid in combination with dipyridamole on the balance between prostacyclin and thromboxane in human serum. Br J Pharmacol. 72:1981;299-303.
12. Patrignani P., Filabozzi P., Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 69:1982;1366-1372.
13. Fitgerald G.A., Oates J.A., Hawiger J., Maas R.I., Roberts L.J., Lawson J.A., Brash A.R. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 71:1983;676-688.
14. Weksler B.B., Pett S.B., Alonso D., Richter R.C., Stelzer P., Subramanian V., Tack-Goldmann K., Gay W.A. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in a atherosclerotic patients. N Engl J Med. 308:1983;800-805.
15. 1 excretion in healthy subjects. Thromb Res. 45:1987;355-361.
16. 2 and prostacyclin in atherosclerotic patients. Thromb Res. 57:1990;437-444.
17. 2 production. Thromb Res. 35:1984;681-687.
18. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after transient ischemic attack or minor ishemic stroke. N Engl J Med. 325:1991;1261-1266.
19. Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary phrophylaxis after cerebrovascular ischaemic events. The Salt Collaborative Group. Lancet 1991;338:1345-9.
20. Doutremepuich C., Aguejouf O., Pintigny D., Sertillanges M.N., De Seze O. Thrombogenic properties of ultra low dose of Acetylsalicylic Acid in a vessel model of laser-induced thrombus formation. Thromb Res. 76:1994;225-229.
21. Doutremepuich C., Aguejouf O., Belon Ph. Effects of ultra-dose aspirin on embplization in a model of laser induced thrombus formation. Seminars in thrombosis and Hemostasis. 22(1):1996;67-70.
22. Belougne-Malfatti E., Aguejouf O., Belon Ph Doutremepuich C. Combination of Two Doses of Acetyl Salicylic Acid. Experimental Study of Arterial Thrombosis Thromb Res. 90:1998;215-221.
23. Vesvres M.H., Doutremepuich F., Lalanne M.C., Doutremepuich C. Effect of aspirin on embolization in an arterial model of laser-induced thrombus formation. Haemost. 23:1993;8-12.
24. Cardinal D., Flower R. The electronic aggregometer. a novel device for assessing platelet behavior in blood J Pharmacological Methods. 135-8:1980.
25. Feldman R.L. Coronary thrombosis, coronary spasm and coronary atherosclerosis and speculation on the link between unstable angina and acute myocardial infarction. Am J Cardiol. 59:1987;1187-1190.
26. Fields W.S. Aspirin for prevention of stroke. a review Am J Med. 14:1983;61-65.
27. Doutremepuich C., De Seze O., Anne M.C., Paccolin J., Quilichini R. Variation du temps de saignement après administration à différentes posologies d'acide acétyl salicylic chez le volontaire sain. Ann Pharmaceutiques françaises. 46:1988;35-39.
28. Aguejouf O., Belougne-Malfatti E., Doutremepuich F., Belon Ph., Doutremepuich C. Thromboembolic Complications Several Days After a Single Dose Administration of Aspirin. Thromb Res. 89:1998;123-127.